Daniel Friedman is listed as a director on 1 SEC Form D filing by 1 issuer in Sep 2024: PBS Biotech, Inc. (Camarillo, CA — biotechnology — 2024; $34.7M reported sold to 3 investors).
What this means One deal on file with the SEC, filed Sep 2024. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Brian Lee (1 shared filing), Dennis Fenton (1 shared filing), Leland foster (1 shared filing), Matt Croughan (1 shared filing), Nelson Bermudez (1 shared filing) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 2 court cases matching the name, 4 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Daniel Friedman and found 6 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Daniel Friedman" (NY) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.